You need JavaScript to view this

Synthesis and evaluation of 1-[l brace]1-[5-(2'-[[sup 18]F]fluoroethyl)-2-thienyl]cyclohexyl[r brace]piperidine as a potential in vivo radioligand for the NMDA receptor-channel complex. [N-methyl-D-aspartate receptor]

Abstract

1-[l brace]1-[5-(2'-[[sup 18]F]Fluoroethyl)-2-thienyl]cyclohexyl[r brace]piperidine ([sup 18]FE-TCP) was prepared a fluorine-substituted analogue of the potent NMDA receptor channel blocker, 1-[1-(2-thienyl)cyclohexyl]piperidine (TCP), by the mesylate displacement with [[sup 18]F]fluoride ion with isolated radiochemical yields of 6-12%, and the synthesis time including a two step HPLC purification was 120 min. The regional distribution in rat brain after i.v. injection of [sup 18]FE-TCP was heterogeneous and similar to the known distribution of phencyclidine recognition sites, with hippocampus-cerebellum, striatum-cerebellum and cerebral cortex-cerebellum concentration ratios of 2.08, 1.7 and 1.54, respectively, 15 min post-injection. Furthermore, this localized regional cerebral distribution was blocked by co-injection with the unlabelled FE-TCP or pretreatment with cis-2-hydroxymethyl-r-1-(N-piperidyl)-1-(2-thienyl)cyclohexane, with the greatest reductions seen in the hippocampus followed by the striatum and cerebral cortex. However, relatively low receptor binding affinity and high non-specific binding due to its high lipophilicity suggest that [sup 18]FE-TCP may not be a suitable radioligand for in vivo PET investigations of the NMDA receptor-channel complex. (Author).
Authors:
Orita, Kazuhiro; Sasaki, Shigeki; Maeda, Minoru; [1]  Hashimoto, Atsushi; Nishikawa, Toru; [2]  Yugami, Tomoko; Umezu, Kohei [3] 
  1. Kyushu Univ., Fukuoka (Japan). Faculty of Pharmaceutical Sciences
  2. National Inst. of Neuroscience, Tokyo (Japan)
  3. Mitsubishi Kasei Corp., Yokohama (Japan). Research Center
Publication Date:
Oct 01, 1993
Product Type:
Journal Article
Reference Number:
AIX-25-033937; EDB-94-077390
Resource Relation:
Journal Name: Nuclear Medicine and Biology (International Journal of Radiation Applications and Instrumentation, Part B); (United Kingdom); Journal Volume: 20:7
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; ASPARTIC ACID; RECEPTORS; TRACER TECHNIQUES; BRAIN; RADIOPHARMACEUTICALS; CHEMICAL PREPARATION; FLUORINE 18; LABELLING; LIGANDS; PIPERIDINES; RATS; AMINES; AMINO ACIDS; ANIMALS; AZINES; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; CARBOXYLIC ACIDS; CENTRAL NERVOUS SYSTEM; DRUGS; FLUORINE ISOTOPES; HETEROCYCLIC COMPOUNDS; HOURS LIVING RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPE APPLICATIONS; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MAMMALS; MEMBRANE PROTEINS; NANOSEC LIVING RADIOISOTOPES; NERVOUS SYSTEM; NUCLEI; ODD-ODD NUCLEI; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANS; PROTEINS; PYRIDINES; RADIOISOTOPES; RODENTS; SYNTHESIS; VERTEBRATES; 550601* - Medicine- Unsealed Radionuclides in Diagnostics
OSTI ID:
5030782
Country of Origin:
United Kingdom
Language:
English
Other Identifying Numbers:
Journal ID: ISSN 0883-2897; CODEN: NMBIEO
Submitting Site:
GBN
Size:
Pages: 865-873
Announcement Date:
Jun 01, 1994

Citation Formats

Orita, Kazuhiro, Sasaki, Shigeki, Maeda, Minoru, Hashimoto, Atsushi, Nishikawa, Toru, Yugami, Tomoko, and Umezu, Kohei. Synthesis and evaluation of 1-[l brace]1-[5-(2'-[[sup 18]F]fluoroethyl)-2-thienyl]cyclohexyl[r brace]piperidine as a potential in vivo radioligand for the NMDA receptor-channel complex. [N-methyl-D-aspartate receptor]. United Kingdom: N. p., 1993. Web.
Orita, Kazuhiro, Sasaki, Shigeki, Maeda, Minoru, Hashimoto, Atsushi, Nishikawa, Toru, Yugami, Tomoko, & Umezu, Kohei. Synthesis and evaluation of 1-[l brace]1-[5-(2'-[[sup 18]F]fluoroethyl)-2-thienyl]cyclohexyl[r brace]piperidine as a potential in vivo radioligand for the NMDA receptor-channel complex. [N-methyl-D-aspartate receptor]. United Kingdom.
Orita, Kazuhiro, Sasaki, Shigeki, Maeda, Minoru, Hashimoto, Atsushi, Nishikawa, Toru, Yugami, Tomoko, and Umezu, Kohei. 1993. "Synthesis and evaluation of 1-[l brace]1-[5-(2'-[[sup 18]F]fluoroethyl)-2-thienyl]cyclohexyl[r brace]piperidine as a potential in vivo radioligand for the NMDA receptor-channel complex. [N-methyl-D-aspartate receptor]." United Kingdom.
@misc{etde_5030782,
title = {Synthesis and evaluation of 1-[l brace]1-[5-(2'-[[sup 18]F]fluoroethyl)-2-thienyl]cyclohexyl[r brace]piperidine as a potential in vivo radioligand for the NMDA receptor-channel complex. [N-methyl-D-aspartate receptor]}
author = {Orita, Kazuhiro, Sasaki, Shigeki, Maeda, Minoru, Hashimoto, Atsushi, Nishikawa, Toru, Yugami, Tomoko, and Umezu, Kohei}
abstractNote = {1-[l brace]1-[5-(2'-[[sup 18]F]Fluoroethyl)-2-thienyl]cyclohexyl[r brace]piperidine ([sup 18]FE-TCP) was prepared a fluorine-substituted analogue of the potent NMDA receptor channel blocker, 1-[1-(2-thienyl)cyclohexyl]piperidine (TCP), by the mesylate displacement with [[sup 18]F]fluoride ion with isolated radiochemical yields of 6-12%, and the synthesis time including a two step HPLC purification was 120 min. The regional distribution in rat brain after i.v. injection of [sup 18]FE-TCP was heterogeneous and similar to the known distribution of phencyclidine recognition sites, with hippocampus-cerebellum, striatum-cerebellum and cerebral cortex-cerebellum concentration ratios of 2.08, 1.7 and 1.54, respectively, 15 min post-injection. Furthermore, this localized regional cerebral distribution was blocked by co-injection with the unlabelled FE-TCP or pretreatment with cis-2-hydroxymethyl-r-1-(N-piperidyl)-1-(2-thienyl)cyclohexane, with the greatest reductions seen in the hippocampus followed by the striatum and cerebral cortex. However, relatively low receptor binding affinity and high non-specific binding due to its high lipophilicity suggest that [sup 18]FE-TCP may not be a suitable radioligand for in vivo PET investigations of the NMDA receptor-channel complex. (Author).}
journal = []
volume = {20:7}
journal type = {AC}
place = {United Kingdom}
year = {1993}
month = {Oct}
}